Second, we also explored the key lncRNA (EMX2OS)‐associated ceRNA network and found that the EMX2OS‐hsa‐miR‐31‐5P‐TLN2 axis could be considered as a precise potential target for future ccRCC therapy. Here, TLN2 is linked to nonpapillary renal cell carcinoma.